800mg CBG-Rich Tincture | Anti-Inflammatory & Energy | Zero THC

The Mother Cannabinoid. Targeted for Inflammation & Energy.

Cannabigerol (CBG) is called the "mother cannabinoid" because all major cannabinoids — CBD, THC, CBN, CBC — are biosynthesized from its acidic precursor CBGA. But CBG is far more than a precursor. It is a direct partial agonist at both CB1 and CB2 receptors — a pharmacological profile that distinguishes it from CBD and makes it particularly relevant for anti-inflammatory and energy applications.

cbdDR's 800mg CBG-Rich Tincture delivers 650mg CBG as the primary active cannabinoid per bottle — a concentration that positions CBG as the dominant therapeutic agent, not a supporting trace element. Formulated in-house by botanical scientist Matthew Scott since 2014. Standardized. Third-party tested every batch.

Formulation Specifications

• Total Cannabinoids: 800mg per 30ml bottle
• Primary Cannabinoid: CBG (Cannabigerol) — 650mg
• Supporting Cannabinoids: CBD — 50mg | CBC — 50mg | CBN — 50mg
• Serving Size: 1ml sublingual
• Servings Per Bottle: ~30
• Cannabinoids Per Serving: ~27mg
• THC: Zero — non-detected on every batch COA
• Carrier: MCT Oil (coconut-derived)
• Administration: Sublingual (under tongue, hold 60–90 seconds)

How CBG Works: The Science

• CB1 receptor partial agonism — CBG directly engages CB1 receptors in the brain and nervous system, contributing to focus, energy, and mood regulation without psychoactive effects
• CB2 receptor partial agonism — CB2 receptors are highly expressed in immune cells; CBG's direct CB2 engagement modulates immune cell activity and cytokine production, supporting anti-inflammatory pathways
• NF-κB pathway inhibition — a 2013 study by Borrelli et al. in Biochemical Pharmacology demonstrated CBG's ability to reduce NF-κB-mediated inflammation in experimental models
• Alpha-2 adrenoreceptor agonism — contributes to pain modulation and may support the energy and focus effects reported by CBG users
• FAAH inhibition — CBG inhibits the enzyme that breaks down anandamide, preserving endocannabinoid tone

Why CBG for Energy?

Unlike CBD, which is primarily associated with calming effects, CBG's direct CB1 receptor engagement and alpha-2 adrenoreceptor activity produce a more activating profile — supporting focus, mental clarity, and energy without stimulants or caffeine. Many users report CBG as their daytime cannabinoid of choice, taken in the morning for sustained focus and anti-inflammatory support throughout the day.

Suggested Use

Place 1ml under tongue using the dropper. Hold for 60–90 seconds. Swallow. Best taken in the morning or early afternoon for energy and focus applications. For anti-inflammatory support, consistent daily use for 2–4 weeks is recommended to assess full effect.

Third-Party Testing

Every batch tested by an ISO/IEC 17025-accredited independent laboratory. Full-panel COA: potency, heavy metals, pesticides, residual solvents, microbials. Results published batch-by-batch in our Batch Database.

Quality Assurance

• ✅ 650mg CBG primary — standardized, not trace amounts
• ✅ Formulated in-house by Matthew Scott, Botanical Scientist
• ✅ Zero THC — verified by independent laboratory testing
• ✅ ISO/IEC 17025-accredited third-party testing every batch
• ✅ No white label — every formulation is our own

View Batch Database →  |  CBG Science Page →  |  CBG Science Article →  |  CBG Dosing Guide →

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare provider before use.